Napsin A and Thyroid Transcription Factor-1-Positive Cerebellar Tumor with Epidermal Growth Factor Receptor Mutation

• Published in: Case reports in oncology Vol. 4; no. 3; pp. 564 - 568
• Main Authors: Kuwata, Taiji, Iwata, Teruo, Iwanami, Takashi
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 07.12.2011; Karger Publishers
• Subjects: Cerebral metastases; Epidermal growth factor receptor mutation; Lung adenocarcinoma; Published: December 2011; Cerebral metastases; Epidermal growth factor receptor mutation; Lung adenocarcinoma
• DOI: 10.1159/000334925
• ISSN: 1662-6575

We present a very rare case of cerebellar metastasis of unknown origin, in which a primary lung adenocarcinoma was diagnosed by pathological examination of a cerebellar metastatic tumor, using immunohistochemical markers and epidermal growth factor receptor (EGFR) mutation of primary lung cancer. A 69-year-old woman was admitted to our hospital because of a hemorrhagic cerebellar tumor and multiple small brain tumors. She underwent cerebellar tumor resection. On pathological examination, the tumor was diagnosed as adenocarcinoma. However, the primary tumor site was unidentifiable even with several imaging inspections. On immunohistochemical analysis, the resected tumor was positive for napsin A and thyroid transcription factor-1. In addition, an EGFR mutation was detected in the tumor. Therefore, primary lung cancer was diagnosed and the patient was started on gefitinib (250 mg/day) therapy.